Favinil 200 - 200mg

Tablet

Pack Size : 10 Tablet x 1 Strip

Generics : Favipiravir (Investigational)

Manufacturer : Square Pharmaceuticals Ltd.

Best Price * TK 2,000.00

* Delivery will be done in Dhaka city only.

Alternative Product

More Information About - Favinil 200 - 200mg

Description

Generic Name

Favipiravir (Investigational)

Precaution

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults. Favipiravir Completed Phase 3 Trials for Flu caused by Influenza Treatment. This drug is only approved as an experimental drug and still a lot of studies is needed about it?s efficacy and also toxic reactions and warning and precaution.

Indication

In 2014, favipiravir was approved in Japan to treat cases of influenza that were unresponsive to conventional treatment. Given its efficacy at targeting several strains of influenza, it has been investigated in other countries to treat novel viruses including Ebola and most recently, COVID-19. Favipiravir has been investigated for the treatment of life-threatening pathogens such as Ebola virus, Lassa virus, and now COVID-19.

Contra Indication

This drug is only approved as an experimental drug and still a lot of studies is needed about its efficacy and also toxic reactions and contraindications.

Dose

N/A

Side Effect

This drug is only approved as an experimental drug and still a lot of studies is needed about it's efficacy and also toxic reactions and other side effects.

Pregnancy Category

Name : Not Classified

Description

FDA has not yet classified the drug into a specified pregnancy category.

Mode of Action

The mechanism of action of favipiravir is novel compared to existing influenza antivirals that primarily prevent entry and exit of the virus from cells. The active favipiravir-RTP selectively inhibits RNA polymerase and prevents replication of the viral genome. There are several hypotheses as to how favipiravir-RTP interacts with RNA dependent RNA polymerase (RdRp). Some studies have shown that when favipiravir-RTP is incorporated into a nascent RNA strand, it prevents RNA strand elongation and viral proliferation. Studies have also found that the presence of purine analogs can reduce favipiravir?s antiviral activity, suggesting competition between favipiravir-RTP and purine nucleosides for RdRp binding.

Interaction

This drug is only approved as an experimental drug and still a lot of studies is needed about it's efficacy and also toxic reactions and drug interactions.

Pregnancy Category Note

It needs to be used with great care and under tight controls because of a serious side effect that could cause fetal abnormalities if a pregnant woman took the drug. It's potential for causing birth defects is one reason it is not used to treat regular flu. For a clinical trial that is under way in Japan, female patients will not be given it if they are pregnant.

Adult Dose

Tablet Adult 1600 mg of Favipiravir administered orally twice daily on Day 1, followed by 600 mg orally twice daily from Day 2 to Day 5. The total treatment duration should be 5 days.

Child Dose

N/A

Renal Dose

N/A

Administration

N/A

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.